Your browser doesn't support javascript.
loading
Pathological and genetic markers improve recurrence prognostication with the University of California Los Angeles Integrated Staging System for patients with clear cell renal cell carcinoma.
Kroeger, Nils; Lebacle, Cédric; Hein, Justine; Rao, P N; Nejati, Reza; Wei, Shuanzeng; Burchardt, Martin; Drakaki, Alexandra; Strother, Marshall; Kutikov, Alexander; Uzzo, Robert; Pantuck, Allan J.
Afiliação
  • Kroeger N; Institute of Urologic Oncology at the Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA; Department of Urology, University of Greifswald, Germany. Electronic address: md.nkroeger@gmail.com.
  • Lebacle C; Institute of Urologic Oncology at the Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA; Department of Urology, University Hospital Bicetre, APHP, University Paris-Saclay, Le Kremlin Bicetre, France.
  • Hein J; Department of Urology, Hospital Magdeburg, Germany.
  • Rao PN; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, USA.
  • Nejati R; Department of Pathology at the Fox Chase Cancer Center, Philadelphia, USA.
  • Wei S; Department of Pathology at the Fox Chase Cancer Center, Philadelphia, USA.
  • Burchardt M; Department of Urology, University of Greifswald, Germany.
  • Drakaki A; Institute of Urologic Oncology at the Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA; Department of Hematology and Oncology, David Geffen School of Medicine at University of California, Los Angeles, USA.
  • Strother M; Department of Urology, Fox Chase Cancer Center, Philadelphia, USA.
  • Kutikov A; Department of Urology, Fox Chase Cancer Center, Philadelphia, USA.
  • Uzzo R; Department of Urology, Fox Chase Cancer Center, Philadelphia, USA.
  • Pantuck AJ; Institute of Urologic Oncology at the Department of Urology, David Geffen School of Medicine at University of California, Los Angeles, USA.
Eur J Cancer ; 168: 68-76, 2022 06.
Article em En | MEDLINE | ID: mdl-35461012
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article